GLP-1 mimetics are available in the clinic for the treatment of type 2 diabetes [2], but several effects of GLP-1 remain unexplained at a mechanistic level, particularly in extrapancreatic tissues. This evidence concerns the gene GLP1R and type 2 diabetes mellitus.